AmoyDx released its performance for the first three quarters, with a net profit attributable to the parent company of 263 million yuan, an increase of 15.50%Zhitong·Oct 24, 2025 at 07:21 AM300685+2.55%
AmoyDx: Net profit in the third quarter was 73.4686 million yuan, a decrease of 11.92%Zhitong·Oct 24, 2025 at 04:07 AM300685+2.55%
AmoyDx plans to increase its investment in upstream gene sequencing company SaiLu Medical by 50 million yuanZhitong·Oct 9, 2025 at 04:14 AM300685+2.55%
Innovative drug concept stocks are repeatedly active, CCHT has two consecutive limit-upsZhitong·Sep 1, 2025 at 08:59 PM688062+2.00%300878-1.36%
AmoyDx released its performance for the first half of the year, with a net profit attributable to the parent company of 189 million yuan, an increase of 31.41%Zhitong·Jul 28, 2025 at 04:33 AM300685+2.55%
AmoyDx: Shareholder Xiamen Keying has completed a reduction of 1.00% of its sharesZhitong·May 14, 2025 at 08:07 AM300685+2.55%
AmoyDx shareholder Xiamen Yixiang plans to reduce its holdings by no more than 3%Zhitong·May 6, 2025 at 09:43 AM300685+2.55%
AmoyDx released its 2024 annual performance, with a net profit attributable to the parent company of 255 million yuan, a year-on-year decrease of 2.53%Zhitong·Apr 21, 2025 at 04:45 AM300685+2.55%
AmoyDx released its first-quarter performance, with a net profit attributable to the parent company of 90.4718 million yuan, a year-on-year increase of 40.92%Zhitong·Apr 21, 2025 at 04:42 AM300685+2.55%
Overview of A-share Stock Buybacks: 15 Companies Disclose Buyback ProgressZhitong·Feb 25, 2025 at 05:36 PM300712+1.32%300685+2.55%
AmoyDx completes repurchase, with a total expenditure of 101 million yuan to repurchase 1.35% of sharesZhitong·Feb 25, 2025 at 04:11 AM300685+2.55%
AmoyDx has repurchased 1.28% of its shares at a cost of 95.0946 million yuanZhitong·Feb 6, 2025 at 06:19 AM300685+2.55%
AmoyDx obtains two medical device registration certificatesZhitong·Jan 13, 2025 at 02:32 AM300685+2.55%
